Sector Chart Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Delayed
NSE India S.E.
07:05:08 2026-10-01 am EDT
|
5-day change | 1st Jan Change | ||
| 2,631.90 INR | -3.11% |
|
-8.21% | +43.19% |
| Sep. 25 | Caplin Point Laboratories Limited Approves Appointment of D Muralidharan as Whole Time Director | CI |
| Aug. 14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,025B | |||||
| 623B | - | ||||
| 459B | |||||
| 355B | |||||
| 336B |
Select your edition
All financial news and data tailored to specific country editions
